Victoria L.  Creamer net worth and biography

Victoria Creamer Biography and Net Worth

Victoria Creamer joined Charles River in January 2019 as Corporate Senior Vice President, Chief People Officer, and was promoted to Corporate Executive Vice President, Chief People Officer in October 2020. In this role, Ms. Creamer leads the Company’s global Human Resources (HR) organization. She is responsible for providing vision and leadership for the Company’s talent and workforce strategy initiatives. This includes identifying and implementing global HR best practices to enhance Charles River’s culture, support a rewarding and engaging work environment, and meet the Company’s growth objectives.

Ms. Creamer is a seasoned global human resources (HR) professional with more than 25 years of experience and a proven track record for leading dynamic HR organizations. Prior to joining Charles River, she was the Senior Vice President, Human Resources and Communications for ITT, Inc. Prior to ITT, Ms. Creamer had a distinguished 20+ year career at IBM, in a variety of HR roles, each with increasing responsibility. Her last role at IBM was Vice President, Global Compensation and Recognition.

Throughout Ms. Creamer’s experience in human resources, she has had a strong focus on workforce issues such as resource planning, retention and attrition, compensation, staffing, and employee and customer survey research. Ms. Creamer has also co-authored several papers on the subject of customer satisfaction, purchase intentions, profitability, and employee satisfaction, which have been presented at the Society for Industrial and Organizational Psychology conferences.

Ms. Creamer received a Master of Arts degree in Psychometrics from Fordham University and holds a Bachelor of Arts degree in Psychology from Hartwick College.

What is Victoria L. Creamer's net worth?

The estimated net worth of Victoria L. Creamer is at least $2.84 million as of February 29th, 2024. Mr. Creamer owns 13,550 shares of Charles River Laboratories International stock worth more than $2,841,706 as of June 19th. This net worth evaluation does not reflect any other assets that Mr. Creamer may own. Learn More about Victoria L. Creamer's net worth.

How do I contact Victoria L. Creamer?

The corporate mailing address for Mr. Creamer and other Charles River Laboratories International executives is 251 BALLARDVALE STREET, WILMINGTON MA, 01887. Charles River Laboratories International can also be reached via phone at (781) 222-6000 and via email at [email protected]. Learn More on Victoria L. Creamer's contact information.

Has Victoria L. Creamer been buying or selling shares of Charles River Laboratories International?

Victoria L. Creamer has not been actively trading shares of Charles River Laboratories International during the last quarter. Learn More on Victoria L. Creamer's trading history.

Who are Charles River Laboratories International's active insiders?

Charles River Laboratories International's insider roster includes William Barbo (VP), Robert Bertolini (Director), Stephen Chubb (Director), Victoria Creamer (EVP), James Foster (CEO), Birgit Girshick (VP), Michael Knell (CAO), Deborah Kochevar (Director), Joseph LaPlume (EVP), George Massaro (Director), Shannon Parisotto (EVP), David Smith (CFO), and Richard Wallman (Director). Learn More on Charles River Laboratories International's active insiders.

Are insiders buying or selling shares of Charles River Laboratories International?

During the last year, Charles River Laboratories International insiders bought shares 3 times. They purchased a total of 7,942 shares worth more than $1,447,729.04. During the last year, insiders at the medical research company sold shares 7 times. They sold a total of 24,170 shares worth more than $5,711,680.74. The most recent insider tranaction occured on May, 10th when EVP Joseph W Laplume sold 1,304 shares worth more than $295,968.88. Insiders at Charles River Laboratories International own 1.3% of the company. Learn More about insider trades at Charles River Laboratories International.

Information on this page was last updated on 5/10/2024.

Victoria L. Creamer Insider Trading History at Charles River Laboratories International

See Full Table

Victoria L. Creamer Buying and Selling Activity at Charles River Laboratories International

This chart shows Victoria L. Creamer's buying and selling at Charles River Laboratories International by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Charles River Laboratories International Company Overview

Charles River Laboratories International logo
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Read More

Today's Range

Now: $209.80
Low: $207.14
High: $211.49

50 Day Range

MA: $224.56
Low: $207.93
High: $247.49

2 Week Range

Now: $209.80
Low: $161.65
High: $275.00


336,121 shs

Average Volume

471,945 shs

Market Capitalization

$10.81 billion

P/E Ratio


Dividend Yield